Angels Santé

MB Therapeutics is a pharmaceutical firm that provides patient-centric solutions for developing and producing tailored medicines.

Sirius NeoSight is a biotechnology and pharmaceutical company focused on the early detection and treatment of subclinical neo-cancers. The company has developed innovative healthcare technology software that measures the fluidity of membranes specifically within the field of oncology. This patented technology is designed to enhance the detection and purification of Circulating Tumor Cells, contributing to advancements in personalized medicine. By addressing these critical aspects of cancer treatment, Sirius NeoSight aims to improve outcomes for patients through early intervention and tailored therapeutic approaches.

SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

Ensweet is a telemedicine platform focused on providing telerehabilitation services to patients. The platform is designed to facilitate accessible rehabilitation care by offering essential equipment, including heart rate sensors and physical activity devices. This enables patients to exercise safely and effectively in various environments, ensuring that rehabilitation is within reach for all individuals regardless of their circumstances.

Healshape is a biotech startup dedicated to developing natural breast reconstruction solutions for women. The company specializes in regenerative medicine, focusing on creating innovative alternatives for breast regeneration through advanced 3D bioprinting technology. Healshape's primary product is a bioprosthesis designed for breast reconstruction, which aims to empower women by helping them regain self-confidence and achieve long-lasting, aesthetically pleasing results following surgery.

Vaxxel is an Innovative viral live-attenuated platform that develops novel and proprietary live-attenuated vaccine candidates against bronchiolitis and pneumonia caused by pneumovirus.

Mapatho operates an online medical directory and search platform that helps patients locate free medical and paramedical experts. The platform is organized by chronic pathologies, addressing the challenge of post-diagnosis medical wandering by connecting patients with relevant health professionals. By fostering a collaborative ecosystem, Mapatho enables individuals with chronic diseases to find specialized care and support, enhancing their ability to navigate the healthcare system effectively.

Gaoma Therapeutics is a biotechnology company dedicated to developing therapeutic molecules aimed at addressing unmet medical needs in neurological and inflammatory diseases. With a particular focus on epilepsy and cognitive disorders, the company is advancing its initial medicine candidate, GAO-3-02, which is a novel proprietary active component. Gaoma Therapeutics also has plans to explore the potential applications of its compounds in additional therapeutic areas, utilizing a portfolio of innovative lipid derivatives as drug candidates to enhance treatment options for healthcare organizations and their patients.

Omini is a French company, established in 2019 and based in Saint Mandé, that specializes in the development of portable and multipurpose bio-sensing devices for blood testing. The company’s biosensor platform allows for the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to tailor therapies and prevent acute crises in patients with chronic conditions. By employing advanced multiplex electrochemical biosensor technology, Omini's devices offer accurate and affordable solutions for identifying, analyzing, and monitoring various target biomarkers. This innovation supports decentralized testing and at-home monitoring, ultimately aiming to alleviate the burden on healthcare systems and improve patient outcomes. Omini primarily serves general practitioners, enhancing their ability to manage patient care effectively.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Hillo is a company based in Palaiseau, France, founded in 2016, specializing in the development of an artificial intelligence platform aimed at transforming the lives of diabetic patients. The company creates tools for continuous blood glucose monitoring that adapt to individual patient needs. Their software synchronizes with insulin delivery devices, logs treatment history, assesses meal intake, and learns from behavioral and physiological responses. This enables real-time predictions of blood glucose levels and provides personalized treatment suggestions, ultimately enhancing diabetes management for patients. Hillo's services are geared toward the medical industry, focusing on improving health outcomes for those living with diabetes.

Wefight Inc. specializes in developing technology for the healthcare sector, focusing on improving personalized patient care. The company's flagship application, Vik-Sein, is designed to assist breast cancer patients by addressing their questions, providing reminders for treatment adherence, and offering smart tracking features to match patients with relevant clinical trials. Founded in 2017 and based in Montpellier, France, Wefight aims to enhance patient support outside of traditional clinical settings. The platform allows for the collection of real-world data, enabling patients to manage their health at home while facilitating more efficient communication between patients and care teams. Additionally, the use of an AI-powered virtual companion helps patients navigate their healthcare journeys and allows doctors to gain insights into their patients' daily experiences with illness.

SentinHealth is a life science company that specializes in developing integrated care solutions aimed at tracking and preventing the progression of chronic illnesses. The company focuses on telemonitoring technology, which includes an implant connected to the cloud that provides daily health status updates and predictive information. This innovative approach is particularly beneficial for patients with serious chronic conditions, as it allows for early detection of health issues, such as acute decompensated heart failure (ADHF), before they require emergency care. By addressing the critical need for continuous monitoring in patients, SentinHealth aims to improve health outcomes and reduce the demand for acute medical interventions.

OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.

C4Diagnostics specializes in the development and commercialization of in vitro diagnostic (IVD) kits utilizing its proprietary technology. The company focuses on creating medical devices and equipment that enhance the speed and sensitivity of diagnostic tests. One of its primary offerings includes solutions for urinary tract infection screening, which reliably detects, counts, and concentrates culturable microorganisms relevant to clinical microbiology. This capability allows hospitals and laboratories to conduct culture-based IVD tests with improved accuracy and efficiency, contributing to better patient outcomes in diagnostic processes.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, specializes in developing non-invasive ultrasonic medical devices aimed at treating heart valve diseases. The company's innovative technology focuses on real-time image guidance to address conditions such as calcified aortic stenosis, minimizing thermal injury and allowing for efficient treatment by clinicians. With a commitment to advancing medical care, Cardiawave has raised over €14 million since its inception to support product development and preclinical studies, paving the way for expected clinical trials to begin. The experienced management team, recognized for its excellence, continues to drive the company's mission to improve patient outcomes in cardiovascular health.

Running Care is a class I medical device (93/42 / EEC) for the diagnosis and rehabilitation of injuries related to running. This medical device is a regulated health product which carries, under these regulations, the CE marking.

Hillo is a company based in Palaiseau, France, founded in 2016, specializing in the development of an artificial intelligence platform aimed at transforming the lives of diabetic patients. The company creates tools for continuous blood glucose monitoring that adapt to individual patient needs. Their software synchronizes with insulin delivery devices, logs treatment history, assesses meal intake, and learns from behavioral and physiological responses. This enables real-time predictions of blood glucose levels and provides personalized treatment suggestions, ultimately enhancing diabetes management for patients. Hillo's services are geared toward the medical industry, focusing on improving health outcomes for those living with diabetes.

Auxivia develops innovative connected glasses aimed at preventing dehydration among individuals who require assistance, particularly the elderly. These smart glasses function like traditional eyewear but incorporate technology that allows for monitoring and traceability of water intake. They feature a reminder system that alerts users to drink water and records the actual quantity consumed. This functionality enables caregivers to effectively manage hydration, ultimately enhancing the quality of life for those with diminished autonomy. By focusing on intelligent services that improve caregiving, Auxivia addresses a critical health concern in vulnerable populations.

Cypheme is a company that has developed an artificial intelligence application focused on detecting counterfeit products. The application utilizes machine learning and pattern recognition techniques to analyze product packaging through a smartphone camera. By examining the micro-structure of items, Cypheme's technology enables users to determine the authenticity of products, helping to combat the growing issue of counterfeit goods in the market. This innovative approach allows for quick and efficient verification, empowering consumers and businesses alike to ensure they are purchasing genuine items.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, specializes in developing non-invasive ultrasonic medical devices aimed at treating heart valve diseases. The company's innovative technology focuses on real-time image guidance to address conditions such as calcified aortic stenosis, minimizing thermal injury and allowing for efficient treatment by clinicians. With a commitment to advancing medical care, Cardiawave has raised over €14 million since its inception to support product development and preclinical studies, paving the way for expected clinical trials to begin. The experienced management team, recognized for its excellence, continues to drive the company's mission to improve patient outcomes in cardiovascular health.

BibeliB is a brand of smart and trendy travel accessories. They created the first smart suit case. This suitcase bag is equipped with e an integrated traceability and insurance system. Thanks to our My BibeliB Paris app your suitcase cover is now connected to geolocate your suitcase and activate it more easily.

Medicapp Connect S.A.S., incorporated in 2011 and based in Paris, France, specializes in designing and developing healthcare software solutions. The company focuses on applications that assist healthcare professionals in managing patient data effectively. Its flagship product, Medicapp EHR, is a mobile application that allows users to create, fill, classify, and communicate patient records, as well as manage health documents and notes. The software aims to simplify recordkeeping for healthcare providers, enhancing the overall efficiency of healthcare data management.